Filter posts

BIO Deputy General Counsel Remarks on Revised Eligibility Guidance

Hans Sauer, BIO’s Deputy General Counsel for Intellectual Property recently spoke at the U.S. Patent …

Sens. Alexander and Burr Release "Innovation for Healthier Americans" Report

Today, Senate HELP Committee Chairman Lamar Alexander (R-Tenn.) and committee member Richard Burr (R-N.C.) released …

Chairman Upton and Rep. DeGette Op-Ed: Can We Find Cures for 7,000 Diseases?

In a CNN.com op-ed, Energy & Commerce Committee Chairman Fred Upton (R-MI) and Representative Diana …

USPTO Issues New Myriad Guidance

On Tuesday, December 16 the United States Patent and Trademark Office issued a revised guidance …

Patently Biotech’s Top Articles of 2014

It’s been a whirlwind year for IP. From international trade negotiations, to revised PTO guidelines …

BIO Coalition Submits Patent Reform Letter to Congress

BIO, alongside a coalition of patent holders and inventors, submitted a letter to the chairmen …

Now What is Patentable?

On Tuesday of the Pacific Rim Summit, experts from Knobbe Martens, BIO, and Synthetic Genomics explored the …

Indian Patents Ensure Wide Access to Drugs, Without Raising Prices

Two recent studies on Indian drugs have shown that patent protection does not dramatically increase …

Patent Trolls and Nigerian Scammers

What do patent trolls and Nigerian princes have in common? Two things come to mind. …

New Report Emphasizes the Role of Patent Protection in the Global Diffusion of New Drugs

A new report from the National Bureau of Economic Research (NBER) has determined that strong …